Did you know?

Oct 31, 2023 · The chart below shows the historical price of ImmunoGen stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ImmunoGen stock price can be found in the table below. ImmunoGen, Inc. ( NASDAQ: IMGN) is being acquired by AbbVie Inc. ( ABBV) at a 94.6% premium or $31.26 per share. The IMGN shares now trade at $29.32, which means there is around a 6.6% upside to ...Nov 24, 2022 · That aside, ImmunoGen is advancing other intriguing molecules such as IMGN-632 (i.e., pivekimab), IMGC-9326, and IMGN-151 for both solid tumors and blood cancers. ImmunoGen Figure 2: Therapeutic ... Nov 20, 2023 · Future criteria checks 5/6. ImmunoGen is forecast to grow earnings and revenue by 65% and 32.8% per annum respectively. EPS is expected to grow by 65.6% per annum. Return on equity is forecast to be 16.8% in 3 years. Sign up. See new TweetsThe chart below shows the historical price of ImmunoGen stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ImmunoGen stock price can be found in the table below.View ImmunoGen, Inc IMGN investment & stock information. Get the latest ImmunoGen, Inc IMGN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.(See IMGN stock forecast on TipRanks)GlobalFoundries (GFS)The next stock we're looking at is GlobalFoundries, a semiconductor contract manufacturer. The company has a 7% market share of the $86 ...28.90R USD −0.4217 −1.44%. The 12 analysts offering 1 year price forecasts for ImmunoGen, Inc. have a max estimate of 31.26 and a min estimate of 19.00.Novartis (NVS) raises its mid-term sales growth outlook by 1%. Find the latest ImmunoGen, Inc. (IMGN) stock quote, history, news and other vital information to help you with your …Analysts have been projecting $14.00 as a low price target for the stock while placing it at a high target of $28.00. It follows that stock’s current price would drop -75.99% in reaching the projected high whereas dropping to the targeted low would mean a gain of 12.01% for stock’s current value. Immunogen, Inc. (IMGN) estimates and forecastsImmunoGen Company Info. ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab ...Turning to the calls side of the option chain, the call contract at the $17.00 strike price has a current bid of $3.00. If an investor was to purchase shares of IMGN stock at the current price ...If you are searching for IMGN stock forecast, analysis or price prediction, then you might be wondering what ImmunoGen, Inc. (IMGN) will do in the future.Our IMGN price …The of IMGN is 0.45, indicating a bullish outlook. FAbbVie reached a deal to acquire ImmunoGen for $31.26 Oct 31, 2023 · The chart below shows the historical price of ImmunoGen stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ImmunoGen stock price can be found in the table below. Here are some of the biggest premarket U.S. stock movers today: Snowflake (NYSE: SNOW ) stock rose 7.7% after the data warehousing company impressed with its third-quarter results, while its guidance pointed to the cloud slowdown coming to an end. Salesforce (NYSE: CRM ) stock rose 9.1% after the cloud software … Weather forecasting plays a crucial role in our d The average price target for Pliant Therapeutics is $47.64. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $63.00 ,the lowest forecast is $34.00. The average price target represents 261.73% Increase from the current price of $13.17. According to analyst projections, HIVE’s forecast low is $6.00 w

Key Insights. The projected fair value for ImmunoGen is US$29.06 based on 2 Stage Free Cash Flow to Equity. Current share price of US$15.37 suggests ImmunoGen is potentially 47% undervalued. Our ...Stock Price Forecast. According to 11 stock analysts, the average 12-month stock price forecast for ImmunoGen stock is $23.93, which predicts a …Dec 1, 2023 · The consensus price target of analysts on Wall Street is $28.57, which implies a decrease of -2.73% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $19.00 and $31.26 respectively. As a result, IMGN is trading at a discount of -6.51% off the target high and 35.26% off the low. Below, we discuss four reasons why adding IMGN stock to your portfolio may prove beneficial in 2023. Favorable Share Price Movement: With therecent launch of Elahere, ImmunoGen was able to ...

With the interplay of data, predictions, and real-time performance, ImmunoGen's stock emerges not just as an investment opportunity but as a narrative unfolding in the grand theatre of the financial markets. Each high, low, surge, and dip is a chapter, and every investor, a reader and co-author of this evolving tale.Every ImmunoGen stock forecast we provide is a fusion of intricate analysis and robust data, aiming to offer a panoramic view of the expected trends. The tumultuous nature of the financial markets, influenced by global economic dynamics, geopolitical events, and ImmunoGen’s own operational performance, implies that short-term stock forecasts ...…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Penny stocks may sound like an interesting investment option, but the. Possible cause: Oct 26, 2023 · With the interplay of data, predictions, and real-time perfo.